Clinical Trial: A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883305) titled 'A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD' on March 03.

Brief Summary: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Intervention: BIOLOGICAL: Tezepelumab

Tezepelumab subcutaneous injection

OTHER: Placebo

Placebo subcutaneous injection

Recruitment Status: NOT_YET...